Moderna said Friday that it aims to deliver 1 billion doses of its COVID-19 vaccine to low-income countries by 2022, in addition to the doses it has already committed to with the global vaccine exchange platform COVAX.
These vaccines will be part of the 2-3 billion doses the company had forecast to produce next year.
“To date, more than 250 million people have been vaccinated worldwide with the Modern COVID-19 vaccine. However, we recognize that access to vaccines remains a challenge in many parts of the world, ”said CEO Stéphane Bancel in a letter posted on the company’s website.
Moderna announced plans Thursday to invest up to $ 500 million to build a factory in Africa to produce up to 500 million doses of mRNA vaccines each year, including its injection of COVID-19.
The company had pledged in May to supply up to 500 million doses of its COVID-19 vaccine to COVAX facilities from the fourth quarter of 2021 to 2022.
“We are committed to doubling our manufacturing and expanding supply even further until our vaccine is no longer needed in low-income countries,” Bancel said.